C/O Cortexyme, Inc., 269 East Grand Ave., South San Francisco, California
Summary
The estimated net worth of Leslie Holsinger is at least $139 K dollars as of June 8, 2022. Leslie Holsinger is the EVP, Preclinical Development of Cortexyme, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $139 K.
Insider Transactions Reported by Leslie Holsinger:
Sym
Company
Class
Transaction
%
Value $
Price $
Shares
Shares After
Date
Ownership
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.